Proximal Tubular Cell-Specific Ablation of Carnitine Acetyltransferase Causes Tubular Disease and Secondary Glomerulosclerosis.
Level 5 - mechanism / opinion, no new human data
Animal knockout model and in vitro cell experiment
PubMed 30728184 · doi:10.2337/db18-0090
What was done
Researchers created a transgenic mouse model with proximal tubular cell-specific deletion of carnitine acetyltransferase (CrAT) to simulate mitochondrial substrate overload. The mice were evaluated for renal pathology, markers of apoptosis, fibrosis, oxidative stress, and metabolic profiles (organic acids and acylcarnitines), both on standard feed and under a high-fat diet challenge. Primary proximal tubular cells from knockout mice were also examined for respiration and energy status before the onset of structural damage.
What was found
The abstract reports no numeric values, effect sizes, or p-values. Qualitatively, CrAT knockout mice developed tubular disease accompanied by secondary glomerulosclerosis, increased apoptosis and fibrosis markers, heightened oxidative stress, and abnormal nutrient metabolism profiles. A high-fat diet accelerated and worsened the severity of kidney disease. Isolated knockout tubular cells showed impaired mitochondrial respiration and energy deficits before overt pathological changes appeared.
Why it matters
The findings demonstrate that primary mitochondrial metabolic failure in proximal tubules can causally initiate tubulointerstitial pathology and secondary glomerular injury, highlighting tubular bioenergetics as a prospective target for chronic kidney disease prevention.
Limits
The study is restricted to mice and isolated cell cultures; clinical relevance to human kidney disease is unconfirmed. The abstract omits sample sizes, specific quantitative measurements, mortality data, and statistical confidence bounds.
Cited by
- contradicts The nephron runs on ketones rather than glucose for its fuel.